Voyager Therapeutics (VT6) Q2 2024 Earnings Report
DE:VT6 Q2 2024 EPS Results
- Actual EPS
- -EUR 0.16
- Consensus EPS
- -EUR 0.36
- Beat/Miss
- Beat by +EUR 0.20
- One Year Ago EPS
- -EUR 0.46
DE:VT6 Q2 2024 Revenue Results
- Actual Revenue
- EUR 26.40M
- Expected Revenue
- EUR 8.49M
- Beat/Miss
- Beat by +EUR 17.91M
- YoY Revenue Growth
- +509.48%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/06/2024
- Time
- After Close
- Conference Call
- Tuesday, August 6, 2024
DE:VT6 Upcoming Earnings
Voyager Therapeutics's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:VT6 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:VT6 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -0.37- | -0.42 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.43-0.36 | -0.51 | 29.82% (+0.15) | |
| May 07, 2026 | 2026 (Q1) | -0.49-0.42 | -0.47 | 11.32% (+0.05) | |
| Mar 09, 2026 | 2025 (Q4) | -0.46-0.41 | -0.53 | 22.03% (+0.12) | |
| Nov 10, 2025 | 2025 (Q3) | -0.46-0.42 | -0.14 | -193.75% (-0.28) | |
| Aug 06, 2025 | 2025 (Q2) | -0.47-0.51 | -0.16 | -216.67% (-0.35) | |
| May 06, 2025 | 2025 (Q1) | -0.40-0.47 | -0.18 | -165.00% (-0.29) | |
| Mar 11, 2025 | 2024 (Q4) | -0.33-0.53 | 1.12 | -147.20% (-1.64) | |
| Nov 12, 2024 | 2024 (Q3) | -0.40-0.14 | -0.53 | 72.88% (+0.38) | |
| Aug 06, 2024 | 2024 (Q2) | -0.36-0.16 | -0.46 | 64.71% (+0.29) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed